Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
GBS Venture Partners is an Australian investment firm focused on venture capital in the life sciences sector. The firm is based in Australia and has notable portfolio companies, including Otsuka Pharmaceutical and the MISHA™ Knee System.
GBS Venture Partners invests in companies within the life sciences sector, targeting various stages of company development. The firm emphasizes innovative products that enhance patient outcomes while generating financial returns for investors.
Notable portfolio companies include Otsuka Pharmaceutical, which is pursuing FDA approval for Centanafadine, a treatment for ADHD, and the MISHA™ Knee System, which has received FDA authorization for marketing.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.